» Articles » PMID: 37542170

Tasmanian Devil Cathelicidins Exhibit Anticancer Activity Against Devil Facial Tumour Disease (DFTD) Cells

Overview
Journal Sci Rep
Specialty Science
Date 2023 Aug 4
PMID 37542170
Authors
Affiliations
Soon will be listed here.
Abstract

The Tasmanian devil (Sarcophilus harrisii) is endangered due to the spread of Devil Facial Tumour Disease (DFTD), a contagious cancer with no current treatment options. Here we test whether seven recently characterized Tasmanian devil cathelicidins are involved in cancer regulation. We measured DFTD cell viability in vitro following incubation with each of the seven peptides and describe the effect of each on gene expression in treated cells. Four cathelicidins (Saha-CATH3, 4, 5 and 6) were toxic to DFTD cells and caused general signs of cellular stress. The most toxic peptide (Saha-CATH5) also suppressed the ERBB and YAP1/TAZ signaling pathways, both of which have been identified as important drivers of cancer proliferation. Three cathelicidins induced inflammatory pathways in DFTD cells that may potentially recruit immune cells in vivo. This study suggests that devil cathelicidins have some anti-cancer and inflammatory functions and should be explored further to determine whether they have potential as treatment leads.

Citing Articles

AMPed up immunity: 418 whole genomes reveal intraspecific diversity of koala antimicrobial peptides.

Petrohilos C, Peel E, Silver L, Belov K, Hogg C Immunogenetics. 2025; 77(1):11.

PMID: 39779522 PMC: 11711154. DOI: 10.1007/s00251-024-01368-2.


Anticancer peptides as novel immunomodulatory therapeutic candidates for cancer treatment.

Sood A, Jothiswaran V, Singh A, Sharma A Explor Target Antitumor Ther. 2024; 5(5):1074-1099.

PMID: 39351437 PMC: 11438574. DOI: 10.37349/etat.2024.00264.

References
1.
Kosack L, Wingelhofer B, Popa A, Orlova A, Agerer B, Vilagos B . The ERBB-STAT3 Axis Drives Tasmanian Devil Facial Tumor Disease. Cancer Cell. 2019; 35(1):125-139.e9. PMC: 6335503. DOI: 10.1016/j.ccell.2018.11.018. View

2.
Ramanathan B, Davis E, Ross C, Blecha F . Cathelicidins: microbicidal activity, mechanisms of action, and roles in innate immunity. Microbes Infect. 2002; 4(3):361-72. DOI: 10.1016/s1286-4579(02)01549-6. View

3.
Azad T, Nouri K, Janse van Rensburg H, Maritan S, Wu L, Hao Y . A gain-of-functional screen identifies the Hippo pathway as a central mediator of receptor tyrosine kinases during tumorigenesis. Oncogene. 2019; 39(2):334-355. DOI: 10.1038/s41388-019-0988-y. View

4.
Peel E, Cheng Y, Djordjevic J, OMeally D, Thomas M, Kuhn M . Koala cathelicidin PhciCath5 has antimicrobial activity, including against Chlamydia pecorum. PLoS One. 2021; 16(4):e0249658. PMC: 8046226. DOI: 10.1371/journal.pone.0249658. View

5.
Murchison E, Schulz-Trieglaff O, Ning Z, Alexandrov L, Bauer M, Fu B . Genome sequencing and analysis of the Tasmanian devil and its transmissible cancer. Cell. 2012; 148(4):780-91. PMC: 3281993. DOI: 10.1016/j.cell.2011.11.065. View